- Home
- FOFO vs VRCA Comparison
FOFO vs VRCA Comparison
Compare FOFO & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOFO | VRCA |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.2M | 87.5M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | FOFO | VRCA |
|---|---|---|
| Price | $4.60 | $5.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 24.0K | ★ 116.4K |
| Earning Date | 03-13-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $35,577,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $92.12 |
| P/E Ratio | $11.09 | ★ N/A |
| Revenue Growth | N/A | ★ 370.22 |
| 52 Week Low | $2.86 | $0.39 |
| 52 Week High | $68.00 | $9.82 |
Technical Indicators
Market Signals| Indicator | FOFO | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 50.42 | 50.78 |
| Support Level | $2.86 | $5.18 |
| Resistance Level | $6.09 | $6.48 |
| Average True Range (ATR) | 0.61 | 0.54 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 31.66 | 55.80 |
Price Performance
Historical ComparisonAbout FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.